ACADIA Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2836 www.acadia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate - Jul 21st, 2026 8:47 am
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis - Jul 20th, 2026 7:05 am
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026 - Jul 15th, 2026 2:05 pm
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors? - Jul 11th, 2026 3:10 pm
ACADIA Pharmaceuticals (ACAD) Names A New Chief People Officer, Is It Still Below Fair Value? - Jul 10th, 2026 8:09 pm
Is ACADIA Pharmaceuticals (ACAD) Still Undervalued After The Daybue Win? - Jul 10th, 2026 8:15 am
How CHMP’s Positive Rett Syndrome Ruling on DAYBU Could Impact ACADIA Pharmaceuticals (ACAD) Investors - Jul 10th, 2026 7:12 am
Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains? - Jul 10th, 2026 3:45 am
RPRX or ACAD: Which Is the Better Value Stock Right Now? - Jul 9th, 2026 9:40 am
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer - Jul 6th, 2026 7:04 am
ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome - Jun 29th, 2026 9:15 am
Strength Seen in Acadia (ACAD): Can Its 6.8% Jump Turn into More Strength? - Jun 29th, 2026 7:37 am
The Surprising Reversal That Drove Acadia Pharma Closer To A Breakout - Jun 26th, 2026 2:24 pm
Sector Update: Healthcare Stocks Gain Late Afternoon - Jun 26th, 2026 1:42 pm
Sector Update: Healthcare Stocks Gain Friday Afternoon - Jun 26th, 2026 11:33 am
Why Acadia Pharmaceuticals Stock Is Soaring Today - Jun 26th, 2026 10:37 am
ACAD Stock Eyes Best Day In Over A Year As CHMP Recommends Approval For Rare Nerve Disorder Drug In Europe - Jun 26th, 2026 10:30 am
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP - Jun 26th, 2026 4:49 am
On second try, Acadia drug gets nod from European regulators - Jun 26th, 2026 3:24 am
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says - Jun 12th, 2026 3:31 am